{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Microtubules : Questions médicales les plus fréquentes",
"headline": "Microtubules : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Microtubules : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-19",
"dateModified": "2025-03-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Microtubules"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cytosquelette",
"url": "https://questionsmedicales.fr/mesh/D003599",
"about": {
"@type": "MedicalCondition",
"name": "Cytosquelette",
"code": {
"@type": "MedicalCode",
"code": "D003599",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.284.430.214.190.750"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Axonème",
"alternateName": "Axoneme",
"url": "https://questionsmedicales.fr/mesh/D054468",
"about": {
"@type": "MedicalCondition",
"name": "Axonème",
"code": {
"@type": "MedicalCode",
"code": "D054468",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.284.430.214.190.750.602.309"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Microtubules",
"alternateName": "Microtubules",
"code": {
"@type": "MedicalCode",
"code": "D008870",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Francesca Bartolini",
"url": "https://questionsmedicales.fr/author/Francesca%20Bartolini",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology & Cell Biology, Columbia University Medical Center, 630 W. 168th Street, New York, NY 10032, USA. Electronic address: fb2131@columbia.edu."
}
},
{
"@type": "Person",
"name": "Marija Zanic",
"url": "https://questionsmedicales.fr/author/Marija%20Zanic",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States."
}
},
{
"@type": "Person",
"name": "Asumi Hoshino",
"url": "https://questionsmedicales.fr/author/Asumi%20Hoshino",
"affiliation": {
"@type": "Organization",
"name": "Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota, USA."
}
},
{
"@type": "Person",
"name": "Valentino Clemente",
"url": "https://questionsmedicales.fr/author/Valentino%20Clemente",
"affiliation": {
"@type": "Organization",
"name": "Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota, USA."
}
},
{
"@type": "Person",
"name": "Mihir Shetty",
"url": "https://questionsmedicales.fr/author/Mihir%20Shetty",
"affiliation": {
"@type": "Organization",
"name": "Masonic Cancer Center and Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, Minnesota, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Optimizing Medical Care during a Nerve Agent Mass Casualty Incident Using Computer Simulation.",
"datePublished": "2024-09-05",
"url": "https://questionsmedicales.fr/article/39235718",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10916-024-02094-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "A computational framework for the multiphysics simulation of microbubble-mediated sonothrombolysis using a forward-viewing intravascular transducer.",
"datePublished": "2023-02-15",
"url": "https://questionsmedicales.fr/article/36812819",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ultras.2023.106961"
}
},
{
"@type": "ScholarlyArticle",
"name": "TemporalGSSA: A numerically robust R-wrapper to facilitate computation of a metabolite-specific and simulation time-dependent trajectory from stochastic simulation algorithm (SSA)-generated datasets.",
"datePublished": "2022-08-08",
"url": "https://questionsmedicales.fr/article/35941839",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1142/S0219720022500184"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of Volunteers' Head Displacement with Computer Simulation-Crash Test with Low Speed of 20 km/h.",
"datePublished": "2022-12-12",
"url": "https://questionsmedicales.fr/article/36560089",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s22249720"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating anticipatory control strategies for their capability to cope with step-down perturbations in computer simulations of human walking.",
"datePublished": "2022-06-16",
"url": "https://questionsmedicales.fr/article/35710689",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-14040-0"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures cellulaires",
"item": "https://questionsmedicales.fr/mesh/D022082"
},
{
"@type": "ListItem",
"position": 4,
"name": "Espace intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D042541"
},
{
"@type": "ListItem",
"position": 5,
"name": "Cytoplasme",
"item": "https://questionsmedicales.fr/mesh/D003593"
},
{
"@type": "ListItem",
"position": 6,
"name": "Structures cytoplasmiques",
"item": "https://questionsmedicales.fr/mesh/D022083"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cytosquelette",
"item": "https://questionsmedicales.fr/mesh/D003599"
},
{
"@type": "ListItem",
"position": 8,
"name": "Microtubules",
"item": "https://questionsmedicales.fr/mesh/D008870"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Microtubules - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Microtubules",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Microtubules",
"description": "Comment diagnostiquer une dysfonction des microtubules ?\nQuels examens sont utilisés pour évaluer les microtubules ?\nLes biopsies peuvent-elles détecter des anomalies des microtubules ?\nQuels marqueurs biologiques sont associés aux microtubules ?\nLes tests génétiques sont-ils utiles pour les maladies liées aux microtubules ?",
"url": "https://questionsmedicales.fr/mesh/D008870?mesh_terms=Computer+Simulation&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Microtubules",
"description": "Quels symptômes indiquent une dysfonction des microtubules ?\nLes douleurs musculaires sont-elles liées aux microtubules ?\nComment les troubles des microtubules affectent-ils le système nerveux ?\nLes troubles de la vision peuvent-ils être liés aux microtubules ?\nY a-t-il des symptômes spécifiques aux maladies des microtubules ?",
"url": "https://questionsmedicales.fr/mesh/D008870?mesh_terms=Computer+Simulation&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Microtubules",
"description": "Comment prévenir les troubles liés aux microtubules ?\nY a-t-il des exercices spécifiques pour soutenir les microtubules ?\nLes antioxydants aident-ils à protéger les microtubules ?\nLa gestion du stress est-elle importante pour la santé cellulaire ?\nLes dépistages réguliers sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D008870?mesh_terms=Computer+Simulation&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Microtubules",
"description": "Quels traitements ciblent les dysfonctionnements des microtubules ?\nLa thérapie génique peut-elle aider les troubles des microtubules ?\nLes traitements symptomatiques sont-ils efficaces ?\nLes approches de médecine régénérative sont-elles prometteuses ?\nLes thérapies physiques sont-elles bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D008870?mesh_terms=Computer+Simulation&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Microtubules",
"description": "Quelles complications peuvent survenir avec des troubles des microtubules ?\nLes troubles des microtubules peuvent-ils entraîner des cancers ?\nY a-t-il des risques de paralysie ?\nLes troubles cognitifs sont-ils une complication possible ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D008870?mesh_terms=Computer+Simulation&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Microtubules",
"description": "Quels facteurs augmentent le risque de troubles des microtubules ?\nL'âge est-il un facteur de risque pour les troubles des microtubules ?\nLes maladies auto-immunes influencent-elles les microtubules ?\nLe stress oxydatif est-il un facteur de risque ?\nLes infections peuvent-elles affecter les microtubules ?",
"url": "https://questionsmedicales.fr/mesh/D008870?mesh_terms=Computer+Simulation&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des microtubules ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de microscopie et des analyses génétiques peuvent révéler des anomalies."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer les microtubules ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La microscopie électronique et les tests de fluorescence sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les biopsies peuvent-elles détecter des anomalies des microtubules ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent montrer des changements dans la structure cellulaire liée aux microtubules."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont associés aux microtubules ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protéines comme la tubuline peuvent servir de marqueurs pour évaluer les microtubules."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les maladies liées aux microtubules ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations dans les gènes codant pour la tubuline."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dysfonction des microtubules ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques, des problèmes de motilité et des anomalies cellulaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les douleurs musculaires sont-elles liées aux microtubules ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements peuvent entraîner des douleurs musculaires et des faiblesses."
}
},
{
"@type": "Question",
"name": "Comment les troubles des microtubules affectent-ils le système nerveux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des troubles de la coordination et des réflexes altérés."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision peuvent-ils être liés aux microtubules ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les microtubules peuvent affecter les cellules rétiniennes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux maladies des microtubules ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'ataxie et la neuropathie peuvent être spécifiques à ces maladies."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux microtubules ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à maintenir la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des exercices spécifiques pour soutenir les microtubules ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des exercices de renforcement musculaire et d'étirement peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Les antioxydants aident-ils à protéger les microtubules ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antioxydants peuvent réduire le stress oxydatif et protéger les cellules."
}
},
{
"@type": "Question",
"name": "La gestion du stress est-elle importante pour la santé cellulaire ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la fonction cellulaire, y compris les microtubules."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers sont-ils recommandés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages peuvent aider à détecter précocement des anomalies cellulaires."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les dysfonctionnements des microtubules ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les taxanes et les inhibiteurs de la tubuline sont utilisés."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle aider les troubles des microtubules ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut corriger des mutations génétiques affectant la tubuline."
}
},
{
"@type": "Question",
"name": "Les traitements symptomatiques sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent soulager les symptômes comme la douleur et la faiblesse musculaire."
}
},
{
"@type": "Question",
"name": "Les approches de médecine régénérative sont-elles prometteuses ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles visent à restaurer la fonction cellulaire en réparant les microtubules."
}
},
{
"@type": "Question",
"name": "Les thérapies physiques sont-elles bénéfiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles aident à améliorer la force et la coordination chez les patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des troubles des microtubules ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, musculaires et des troubles de la motilité peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les troubles des microtubules peuvent-ils entraîner des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les microtubules sont associées à certains types de cancers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de paralysie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements graves peuvent entraîner des paralysies ou des troubles moteurs."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils une complication possible ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs peuvent survenir en raison de l'impact sur le système nerveux."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de troubles des microtubules ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, environnementaux et liés au mode de vie peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les troubles des microtubules ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la fonction des microtubules et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes influencent-elles les microtubules ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent perturber la fonction cellulaire et affecter les microtubules."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut endommager les microtubules et affecter leur fonction."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles affecter les microtubules ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent perturber la structure et la fonction des microtubules."
}
}
]
}
]
}
Chemical mass casualty incidents (MCIs) pose a substantial threat to public health and safety, with the capacity to overwhelm healthcare infrastructure and create societal disorder. Computer simulatio...
We created a computer simulation model of an urban subway sarin attack analogous to the 1995 Tokyo sarin incident. We created and combined evacuation, dispersion and victim models with the SIMEDIS com...
Only evacuation policy, strategy and preliminary triage show significant effects on mortality. The total average mortality ranges from 14.7 deaths in the combination of off-site decontamination and Sc...
Our findings suggest that in a simulated urban chemical MCI, a Stay and Play approach with on-site decontamination will lead to worse outcomes than a Scoop and Run approach with hospital-based deconta...
Sonothrombolysis is a technique that utilises ultrasound waves to excite microbubbles surrounding a clot. Clot lysis is achieved through mechanical damage induced by acoustic cavitation and through lo...
Whilst data on biochemical networks has increased several-fold, our comprehension of the underlying molecular biology is incomplete and inadequate. Simulation studies permit data collation from dispar...
Recently, the automotive industry has used simulation programs much more often than experimental research. Computer simulations are more and more often used due to the repeatability of simulation cond...
Previous simulation studies investigated the role of reflexes and central pattern generators to explain the kinematic and dynamic adaptations in reaction to step-down perturbations. However, experimen...
Compared to traditional unipolar radiofrequency ablation (RFA), bipolar RFA offers advantages such as more precise heat transfer and higher ablation efficiency. Clinically, myocardial baseline impedan...
Stroke, a major global health concern often rooted in cardiac dynamics, demands precise risk evaluation for targeted intervention. Current risk models, like the...
To develop and validate a novel, microsimulation model that accounts for the prevalence and incidence of age-associated dementias (AAD), disease progression and associated mortality....
We developed the AAD policy (AgeD-Pol) model, a microsimulation model to simulate the natural history, morbidity and mortality associated with AAD. We populated the model with age-stratified and sex-s...
In internal validation, the AgeD-Pol model provided a good fit to the ACT cohort for cumulative AAD incidence, 10.4% (MAPE, 0.2%) and survival, 66.5% (MAPE, 8.8%), after 16 years of follow-up among th...
The AgeD-Pol model performed well when validated to published data for AAD cumulative incidence and mortality and provides a useful tool to project the AAD disease burden for health systems planning i...
Transferring individuals for treatment outside their geographic area occurs when healthcare demand exceeds local supply. This can result in significant financial cost while impacting patient outcomes ...
The aim of this study was to assess initiatives to reduce psychiatric intensive care unit (PICU) out-of-area bed placements within a major healthcare system in South West England....
Discrete event computer simulation was used to model patient flow across the healthcare system's three PICUs. A scenario analysis was performed to estimate the impact of management plans to decrease a...
Without increasing in-area capacity, mean out-of-area bed requirement can be reduced by 25.6% and 19.1% respectively through plausible initiatives to decrease admissions and length of stay. Reductions...
This study supports the likely effectiveness of particular initiatives in reducing out-of-area placements for high-acuity bedded psychiatric care. This study also demonstrates the value of computer si...
This study uses Digital Human Modelling (DHM) and Discrete Event Simulation (DES) to examine how caring for COVID-19-positive (C+) patients affects nurses' workload and care-quality. DHM inputs includ...